Langenberg & Company Downgrades Chelsea Therapeutics (CHTP) to Hold
Tweet
Share
E-mailGet Alerts CHTP Hot Sheet
Price: $6.52 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Join SI Premium – FREE
Langenberg & Company downgraded Chelsea Therapeutics (NASDAQ: CHTP) from Buy to Hold.
For an analyst ratings summary and ratings history on Chelsea Therapeutics click here. For more ratings news on Chelsea Therapeutics click here.
Shares of Chelsea Therapeutics closed at $3.67 yesterday.
For an analyst ratings summary and ratings history on Chelsea Therapeutics click here. For more ratings news on Chelsea Therapeutics click here.
Shares of Chelsea Therapeutics closed at $3.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- UBS Downgrades Alsea SAB de CV (ALSEA:MM) (ALSSF) to Neutral
- BHP (BHP:LN) (BHP) PT Raised to GBP28.25 at Barclays
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
